![](/img/cover-not-exists.png)
Phase I safety and antigenicity of TA-GW: a recombinant HPV6 L2E7 vaccine for the treatment of genital warts
H.S.G Thompson, M.L Davies, F.P Holding, R.E Fallon, A.E Mann, T O'Neill, J St Clair RobertsVolume:
17
Year:
1999
Language:
english
DOI:
10.1016/s0264-410x(98)00146-7
File:
PDF, 368 KB
english, 1999